Synolis V-A is a unique combination of high molecular weight and high concentration Hyaluronic Acid and a high concentration Sorbitol (patent pending). Sorbitol is to protect HA from degradation, preserving the benefits of Synolis V-A human-like visco-elasticity properties for a longer period. This improved stability together with the anti-oxidant property of Sorbitol is translated into a superior clinical benefit that was named “The V-A Effect”.
Synolis V-A is indicated for fast, intense and prolonged pain relief in patients with synovial joint Osteoarthritis. The concerned joints are usually knees, hips and shoulders, but all the other synovial joints such as fingers, ankles, jaw can be treated. Synolis V-A injection regimen is flexible, with 1 to 3 injections depending on disease severity.